Epidermal growth factor receptor mutations in non-small cell lung cancer: Predicting clinical response to kinase inhibitors

被引：19
|
作者：
Sequist, LV [1 ]
Haber, DA [1 ]
Lynch, TJ [1 ]
机构：
[1] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA
来源：
CLINICAL CANCER RESEARCH | 2005年 / 11卷 / 16期
关键词：
D O I：
10.1158/1078-0432.CCR-05-1055
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：5668 / 5670
页数：3
相关论文
共 50 条
  • [1] Epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer
    Asami, Kazuhiro
    Atagi, Shinji
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2014, 5 (04): : 646 - 659
  • [2] Clinical characteristics and response to tyrosine kinase inhibitors of patients with non-small cell lung cancer harboring uncommon epidermal growth factor receptor mutations
    Zhang, Yan
    Wang, Zheng
    Hao, Xuezhi
    Hu, Xingsheng
    Wang, Hongyu
    Wang, Yan
    Ying, Jianming
    CHINESE JOURNAL OF CANCER RESEARCH, 2017, 29 (01) : 18 - 24
  • [3] Clinical characteristics and response to tyrosine kinase inhibitors of patients with non-small cell lung cancer harboring uncommon epidermal growth factor receptor mutations
    Yan Zhang
    Zheng Wang
    Xuezhi Hao
    Xingsheng Hu
    Hongyu Wang
    Yan Wang
    Jianming Ying
    ChineseJournalofCancerResearch, 2017, 29 (01) : 18 - 24
  • [4] Epidermal growth factor receptor inhibitors in non-small cell lung cancer
    Dancey, Janet E.
    DRUGS, 2007, 67 (08) : 1125 - 1138
  • [5] Epidermal Growth Factor Receptor Inhibitors in Non-Small Cell Lung Cancer
    Janet E. Dancey
    Drugs, 2007, 67 : 1125 - 1138
  • [6] Mutations in the tyrosine kinase domain of the epidermal growth factor receptor in non-small cell lung cancer
    Yang, SH
    Mechanic, LE
    Yang, P
    Landi, MT
    Bowman, ED
    Wampfler, J
    Meerzaman, D
    Hong, KM
    Mann, F
    Dracheva, T
    Fukuoka, J
    Travis, W
    Caporaso, NE
    Harris, CC
    Jen, A
    CLINICAL CANCER RESEARCH, 2005, 11 (06) : 2106 - 2110
  • [7] Effectiveness of Tyrosine Kinase Inhibitors on "Uncommon" Epidermal Growth Factor Receptor Mutations of Unknown Clinical Significance in Non-Small Cell Lung Cancer
    Wu, Jenn-Yu
    Yu, Chong-Jen
    Chang, Yeun-Chung
    Yang, Chih-Hsin
    Shih, Jin-Yuan
    Yang, Pan-Chyr
    CLINICAL CANCER RESEARCH, 2011, 17 (11) : 3812 - 3821
  • [8] Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer
    Kujtan, Lara
    Subramanian, Janakiraman
    EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (07) : 547 - 559
  • [9] Resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer
    周清
    魏雪武
    高欣
    何韵婷
    杨潇蓉
    Science Foundation in China, 2019, 27 (01) : 72 - 80
  • [10] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advanced Non-Small Cell Lung Cancer
    Ogunleye, Foluso
    Ibrahim, Mohammed
    Stender, Michael
    Kalemkerian, Gregory
    Jaiyesimi, Ishmael
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2015, 11 (01) : 16 - 25
12345